Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
(R)-3-[6-[2-(2,6-Dichlorobenzyloxy)ethoxy]hexyl]-5-(2,2-dimethyl-4H-benzo[1,3]dioxin-6-yl)oxazolidin-2-one is an intermediate in the preparation of Vilanterol Trifenatate (V260000), a long-acting β2 adrenergic receptor agonist.